1
|
Constantinides PP, Chakraborty S, Shukla D. Considerations and recommendations on traditional and non-traditional uses of excipients in oral drug products. AAPS OPEN 2016. [DOI: 10.1186/s41120-016-0004-3] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022] Open
|
2
|
Sjögren E, Abrahamsson B, Augustijns P, Becker D, Bolger MB, Brewster M, Brouwers J, Flanagan T, Harwood M, Heinen C, Holm R, Juretschke HP, Kubbinga M, Lindahl A, Lukacova V, Münster U, Neuhoff S, Nguyen MA, Peer AV, Reppas C, Hodjegan AR, Tannergren C, Weitschies W, Wilson C, Zane P, Lennernäs H, Langguth P. In vivo methods for drug absorption – Comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects. Eur J Pharm Sci 2014; 57:99-151. [DOI: 10.1016/j.ejps.2014.02.010] [Citation(s) in RCA: 196] [Impact Index Per Article: 19.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2013] [Revised: 02/15/2014] [Accepted: 02/17/2014] [Indexed: 01/11/2023]
|
3
|
Kubbinga M, Moghani L, Langguth P. Novel insights into excipient effects on the biopharmaceutics of APIs from different BCS classes: Lactose in solid oral dosage forms. Eur J Pharm Sci 2014; 61:27-31. [PMID: 24732384 DOI: 10.1016/j.ejps.2014.03.008] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2014] [Revised: 03/25/2014] [Accepted: 03/31/2014] [Indexed: 12/21/2022]
Abstract
Excipients encompass a wide range of properties that are of importance for the resulting drug product. Regulatory guidelines on biowaivers for immediate release formulations require an in depth understanding of the biopharmaceutic effects of excipients in order to establish bioequivalence between two different products carrying the same API based on dissolution tests alone. This paper describes a new approach in evaluating biopharmaceutic excipient effects. Actually used quantities of a model excipient, lactose, formulated in combination with APIs from different BCS classes were evaluated. The results suggest that companies use different (relative) amounts depending on the characteristics of the API. The probability of bioinequivalence due to a difference in lactose content between test and reference products was classified as low for BCS class I APIs and medium for BCS class II and III APIs, whereas a high probability was assigned to the combination of lactose and BCS class IV APIs. If repeated for other excipients, this retrospective, top-down approach may lead to a new database and more widespread applications of the biowaiver approach.
Collapse
Affiliation(s)
- Marlies Kubbinga
- National Institute for Public Health and the Environment, Bilthoven, The Netherlands; Pharmaceutical Technology and Biopharmaceutics, Johannes Gutenberg University Mainz, Mainz, Germany; Medicines Evaluation Board, Utrecht, The Netherlands
| | - Laura Moghani
- Pharmaceutical Technology and Biopharmaceutics, Johannes Gutenberg University Mainz, Mainz, Germany
| | - Peter Langguth
- Pharmaceutical Technology and Biopharmaceutics, Johannes Gutenberg University Mainz, Mainz, Germany.
| |
Collapse
|
4
|
|
5
|
Heinen C, Reuss S, Saaler-Reinhardt S, Langguth P. Mechanistic basis for unexpected bioavailability enhancement of polyelectrolyte complexes incorporating BCS class III drugs and carrageenans. Eur J Pharm Biopharm 2013; 85:26-33. [DOI: 10.1016/j.ejpb.2013.03.010] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2012] [Revised: 03/07/2013] [Accepted: 03/11/2013] [Indexed: 10/26/2022]
|
6
|
Heinen CA, Reuss S, Amidon GL, Langguth P. Ion Pairing with Bile Salts Modulates Intestinal Permeability and Contributes to Food–Drug Interaction of BCS Class III Compound Trospium Chloride. Mol Pharm 2013; 10:3989-96. [DOI: 10.1021/mp400179v] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Christian A. Heinen
- Department of Pharmaceutical Technology & Biopharmaceutics, Johannes Gutenberg University, Staudingerweg 5, 55128 Mainz, Germany
| | - Stefan Reuss
- Department of Nuclear Medicine, University Medical Center, Johannes Gutenberg University, Langenbeckstr. 1, 55101 Mainz, Germany
| | - Gordon L. Amidon
- College of Pharmacy, The University of Michigan, 428 Church Street, Ann
Arbor, Michigan 48109-1065, United States
| | - Peter Langguth
- Department of Pharmaceutical Technology & Biopharmaceutics, Johannes Gutenberg University, Staudingerweg 5, 55128 Mainz, Germany
| |
Collapse
|
7
|
Sevimli S, Inci F, Zareie HM, Bulmus V. Well-Defined Cholesterol Polymers with pH-Controlled Membrane Switching Activity. Biomacromolecules 2012; 13:3064-75. [DOI: 10.1021/bm300846e] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Affiliation(s)
| | - Fatih Inci
- Department of Molecular
Biology-Genetics and Biotechnology Program (MOBGAM), Istanbul Technical University, Istanbul 34469, Turkey
| | - Hadi M. Zareie
- Department of Electrical-Electronics
Engineering and Nanotechnology Graduate Program, Gediz University, Izmir 35665, Turkey
- Microstructural
Analysis Unit, School of Physics and Advanced Materials, University of Technology, Sydney, Altimo NSW 2007,
Australia
| | | |
Collapse
|
8
|
Romero VL, Pons P, Bocco JL, Manzo RH, Alovero FL. Eudragit E100® potentiates the bactericidal action of ofloxacin against fluoroquinolone-resistant Pseudomonas aeruginosa. FEMS Microbiol Lett 2012; 334:102-10. [DOI: 10.1111/j.1574-6968.2012.02626.x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2012] [Revised: 05/30/2012] [Accepted: 06/18/2012] [Indexed: 12/01/2022] Open
Affiliation(s)
- Verónica L. Romero
- Departamento de Farmacia; Facultad de Ciencias Químicas; Universidad Nacional de Córdoba; Córdoba; Argentina
| | - Patricia Pons
- Centro de Microscopía Electrónica; Facultad de Ciencias Médicas; Universidad Nacional de Córdoba; Córdoba; Argentina
| | - José L. Bocco
- Departamento de Bioquímica Clínica; Facultad de Ciencias Químicas; Universidad Nacional de Córdoba; Córdoba; Argentina
| | - Rubén H. Manzo
- Departamento de Farmacia; Facultad de Ciencias Químicas; Universidad Nacional de Córdoba; Córdoba; Argentina
| | - Fabiana L. Alovero
- Departamento de Farmacia; Facultad de Ciencias Químicas; Universidad Nacional de Córdoba; Córdoba; Argentina
| |
Collapse
|
9
|
|
10
|
Yu Q, Najun L, Qingfeng X, Jianfeng G, Xuewei X, Jianmei L. Synthesis and characterization of a new amphiphilic copolymer containing multihydroxyl segments for drug carrier. J Appl Polym Sci 2011. [DOI: 10.1002/app.33912] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
11
|
Obermeier B, Langguth P, Frey H. Partially Quarternized Amino Functional Poly(methacrylate) Terpolymers: Versatile Drug Permeability Modifiers. Biomacromolecules 2010; 12:425-31. [DOI: 10.1021/bm1012037] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Boris Obermeier
- Institute of Organic Chemistry, Organic and Macromolecular Chemistry, Duesbergweg 10-14, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany, and Institute of Pharmacy, Department of Biopharmaceutics and Pharmaceutical Technology, Staudingerweg 5, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - Peter Langguth
- Institute of Organic Chemistry, Organic and Macromolecular Chemistry, Duesbergweg 10-14, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany, and Institute of Pharmacy, Department of Biopharmaceutics and Pharmaceutical Technology, Staudingerweg 5, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - Holger Frey
- Institute of Organic Chemistry, Organic and Macromolecular Chemistry, Duesbergweg 10-14, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany, and Institute of Pharmacy, Department of Biopharmaceutics and Pharmaceutical Technology, Staudingerweg 5, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| |
Collapse
|